Successful Grant: Raylab with CNAO and partners in the funded PROGRESS BNCT@CNAO Project

Raylab, together with the lead institution Fondazione CNAO (National Center for Oncological Hadrontherapy) and the other partners – Fondazione IRCCS Policlinico San Matteo, Visiorobotics Srl, Else Solutions, and Hifuture Srl – is pleased to announce the launch of the project PROGRESS BNCT@CNAO (Id: 6170035), dedicated to the development of the new BNCT facility at CNAO.

The project has been approved and funded by Regione Lombardia, the European Union, and the Italian Republic under the Collabora&Innova call for proposals, supported by the European Regional Development Fund (FESR 2021–2027).

This initiative aims to foster innovation in the field of cancer therapies in Lombardy, bringing together leading Italian expertise in advanced therapeutic technologies, research institutions, clinical organizations, and industry.

Over its 27-month duration, the partnership will work on the creation of an integrated pre-clinical ecosystem, unique on the global stage, designed to promote highly complex technological treatment options for patients affected by rare oncological diseases.